Box 4
Container
Contains 8 Results:
Smith, Kline & French - Scientific Liaison Activities - Reports and Correspondence - (This includes the “Resume of Scientific Liaison Activities for 1973” report by Ullyot.) - (This file was prepared while Ullyot was Director of Scientific Liaison at Smith, Kline & French.), 1971-1974
File — Box: 4, Folder: 1
Dates:
1971-1974
Smith, Kline & French - “A Brief History of SmithKline Corporation”, 1976 May
File — Box: 4, Folder: 2
Dates:
1976 May
Smith, Kline & French - “This Fine Old House - Part I: The Beginning” - SmithKline Dimensions, Volume II, Number 3, 1977 May-June
File — Box: 4, Folder: 3
Dates:
1977 May-June
Smith, Kline & French - Dr. Robert R. Raffauf (Science Information Department) - Correspondence with Ullyot, 1993-2001
File — Box: 4, Folder: 4
Dates:
1993-2001
Smith, Kline & French - “The Discovery of Histamine H2 - Receptor Antagonists” - American Chemical Society International Historic Chemical Landmark (This discovery led to the development of Tagamet which was used for the treatment of peptic ulcers.), 1997 November 24, 1998 February 6
File — Box: 4, Folder: 5
Dates:
1997 November 24, 1998 February 6
Smith, Kline & French - Letter from Bernard Loev to Glenn and Barbara Ullyot discussing dihydropyridines, undated
File — Box: 4, Folder: 6
Dates:
undated
Smith, Kline & French - Ullyot, G.E., “The Evolution of Quotane” - Smith, Kline & French In-House Lecture - (This lecture traces the steps by which Quotane was synthetized, tested and brought into the marketplace for use as a topical anesthetic.), undated
File — Box: 4, Folder: 7
Dates:
undated